Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing ManagementThe Neurologist 8:227-236, Frohman,E.,et al, 2002
Clinicopathologic Conference, Systemic Juvenile Idiopathic ArthritisNEJM 385:1220-1229, Case 29-2021, 2021